A238L inhibits NF-ATc2, NF-kappa B, and c-Jun activation through a novel mechanism involving protein kinase C-theta-mediated up-regulation of the amino-terminal transactivation domain of p300

The Journal of Immunology (2008) - Comments
pubmed: 18250452 issn: 0022-1767 doi: 10.4049/jimmunol.180.4.2429 issn: 1550-6606

Aitor G. Granja, Neil D. Perkins, Yolanda Revilla